MedicaidCoverageMedium impact
Asthma Inhaler Update
Missouri Medicaid (MO HealthNet)·MO · Family Medicine, Internal Medicine, Pediatrics +2 more·Provider Notice
Effective date
Jan 25, 2024
We identified it
Jun 20, 2026
Summary
MO HealthNet has made temporary changes to their asthma inhaler coverage due to nationwide shortages of Asmanex HFA and discontinuation of brand Flovent HFA. Generic Fluticasone Propionate HFA is now a preferred agent, and certain inhalers remain available for pediatric patients under 12 without prior authorization requirements.
Action Required
Immediately: Billing team must update prior authorization requirements for MO HealthNet patients with asthma inhalers. Verify that generic Fluticasone Propionate HFA, Arnuity Ellipta, and Asmanex Twisthaler are processed as preferred agents without prior auth. For pediatric patients under 12, ensure Dulera 50mcg/5mcg and Asmanex HFA can be billed as first-line therapy without prerequisite trials. Update encounter forms to reflect new preferred agent status.